Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 311 Neoplasm Metastasis 38 Neoplasms 22 Advanced Breast Cancer 19 Ovarian Neoplasms 18 Carcinoma, Non-Small-Cell Lung 14 Endometrial Neoplasms 11 Prostatic Neoplasms 10 Hereditary Sensory and Autonomic Neuropathies 10 Triple Negative Breast Neoplasms 8 Colorectal Neoplasms 6 Breast Cancer Metastatic 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Recurrence 5 Carcinoma, Ovarian Epithelial 5 Neoplasms by Site 4 Multiple Endocrine Neoplasia Type 1 4 Breast Diseases 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Lobular 3 Uterine Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2

Interventions

Sevoflurane 1 Propofol 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Female Breast Carcinoma × Fulvestrant × Clear all

NCT02540330 2024-04-03

007

Atossa Therapeutics, Inc.

Phase 2 Terminated

3 enrolled 7 charts

Female Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡